Etiologic Stroke Subtypes: Updated Definition and Efficient Workup Strategies

Current Treatment Options in Cardiovascular Medicine

Volumn 17, Issue 1, 2015, Pages

  Mehndiratta, Prachi ^a   Chapman Smith, Sherita ^b   Worrall, Bradford B ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Etiology; Ischemic stroke; Stroke classification; Stroke definition; Stroke imaging; Stroke subtype

Indexed keywords

ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBRAL VENOUS SINUS THROMBOSIS; CEREBROVASCULAR ACCIDENT; DISEASE CLASSIFICATION; EMBOLISM; FIBROMUSCULAR DYSPLASIA; HUMAN; MOYAMOYA DISEASE; REVIEW; THROMBOSIS; VASOSPASM;

EID: 84911478690     PISSN: 10928464     EISSN: 15343189     Source Type: Journal    
DOI: 10.1007/s11936-014-0357-7     Document Type: Review

References (42)

1. Feigin VL et al. Global and regional burden of stroke during 1990-2010: Findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245–54.
2. Lozano R et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.
3. Jorgensen HS et al. Stroke recurrence: predictors, severity, and prognosis. The Copenhagen Stroke Study. Neurology. 1997;48(4):891–5.
4. Goldstein LB et al. Guidelines for the primary prevention of stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(2):517–84.
5. Capildeo R, Haberman S, Rose FC. The definition and classification of stroke. A new approach. Q J Med. 1978;47(186):177–96.
6. Go AS et al. Executive summary: heart disease and stroke statistics–2014 update: A report from the American Heart Association. Circulation. 2014;129(3):399–410.
7. Group SPSS et al. Blood-pressure targets in patients with recent lacunar stroke: The SPS3 randomised trial. Lancet. 2013;382(9891):507–15.
8. Barnett HJ et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998;339(20):1415–25.
9. Johnson CJ et al. Interrater reliability of an etiologic classification of ischemic stroke. Stroke. 1995;26(1):46–51.
10. Ay H et al. An evidence-based causative classification system for acute ischemic stroke. Ann Neurol. 2005;58(5):688–97.
11. Ay H et al. A computerized algorithm for etiologic classification of ischemic stroke: The Causative Classification of Stroke System. Stroke. 2007;38(11):2979–84.
12. Amarenco P et al. New approach to stroke subtyping: The A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis. 2009;27(5):502–8.
13. Adams Jr HP et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41.
14. Mead GE et al. How well does the Oxfordshire community stroke project classification predict the site and size of the infarct on brain imaging? J Neurol Neurosurg Psychiatry. 2000;68(5):558–62.
15. Asdaghi N et al. Oxfordshire community stroke project classification poorly differentiates small cortical and subcortical infarcts. Stroke. 2011;42(8):2143–8.
16. McArdle PF, Kittner SJ, Ay H, Brown RD Jr, Meschia JF, Rundek T, et al. Agreement between TOAST and CCS ischemic stroke classification. The NINDS SiGN Study. Neurology. 2014. doi:10.1212/WNL.0000000000000942
17. Lin HJ et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke. 1996;27(10):1760–4.
18. Gladstone DJ et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370(26):2467–77. This article demonstrated the advantage of extended cardiac monitoring for 30 days after a cryptogenic stroke in detection of atrial fibrillation.
19. Sanna T et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478–86.
20. Pearson AC et al. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol. 1991;17(1):66–72.
21. Mojadidi MK et al. Diagnostic accuracy of transesophageal echocardiogram for the detection of patent foramen ovale: A meta-analysis. Echocardiography. 2014;31(6):752–8.
22. Go AS et al. Heart disease and stroke statistics–2013 update: A report from the American Heart Association. Circulation. 2013;127(1):e6–245.
23. Gage BF et al. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22):2864–70.
24. Olesen JB et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011;342:d124.
25. Jauch EC et al. Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947.
26. Fine-Edelstein JS et al. Precursors of extracranial carotid atherosclerosis in the Framingham Study. Neurology. 1994;44(6):1046–50.
27. Sliwka U et al. Occurrence of transcranial Doppler high-intensity transient signals in patients with potential cardiac sources of embolism. A prospective study. Stroke. 1995;26(11):2067–70.
28. Erdoes G et al. Transcranial Doppler-detected cerebral embolic load during transcatheter aortic valve implantation. Eur J Cardiothorac Surg. 2012;41(4):778–83. discussion 783-4.
29. Martin KK et al. Intraoperative cerebral high-intensity transient signals and postoperative cognitive function: A systematic review. Am J Surg. 2009;197(1):55–63.
30. Wasserman BA. Advanced contrast-enhanced MRI for looking beyond the lumen to predict stroke: building a risk profile for carotid plaque. Stroke. 2010;41(10 Suppl):S12–6. This article emphasizes the role of contrast enhanced MRI in evaluating carotid plaques and risk of recurrent stroke.
31. Fisher CM. Lacunar strokes and infarcts: A review. Neurology. 1982;32(8):871–6.
32. Kinoshita T et al. Assessment of lacunar hemorrhage associated with hypertensive stroke by echo-planar gradient-echo T2*-weighted MRI. Stroke. 2000;31(7):1646–50.
33. Vagal AS et al. The acetazolamide challenge: Techniques and applications in the evaluation of chronic cerebral ischemia. AJNR Am J Neuroradiol. 2009;30(5):876–84.
34. Finsterer J. Management of cryptogenic stroke. Acta Neurol Belg. 2010;110(2):135–47.
35. Kernan WN et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160–236.
36. Thaler DE et al. Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs. Neurology. 2014;83(3):221–6.
37. Nayor M, Maron BA. Contemporary approach to paradoxical embolism. Circulation. 2014;129(18):1892–7. This article describes systematically how to approach a patient with suspected paradoxical embolism.
38. Amarenco P et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med. 1994;331(22):1474–9.
39. Amarenco P. Underlying pathology of stroke of unknown cause (cryptogenic stroke). Cerebrovasc Dis. 2009;27 Suppl 1:97–103.
40. Amarenco P et al. Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke. 2014;45(5):1248–57.
41. Tayal AH et al. Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology. 2008;71(21):1696–701.
42. Meschia JF, Tournier-Lasserve E. Advances in stroke: genetics 2012. Stroke. 2013;44(2):309–10.